Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 474

1.

Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis - ERRATUM.

Wu Y, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Conwell Y, de Manvan Ginkel JM, Fann JR, Fischer FH, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Harrison PA, Härter M, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki M, Jetté N, Khamseh ME, Kiely KM, Kwan Y, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, McGuire A, Mohd-Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Reuter K, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford L, Sung S, Tan PLL, Turner A, van Weert HC, White J, Whooley MA, Winkley K, Yamada M, Benedetti A, Thombs BD.

Psychol Med. 2019 Aug 19:1. doi: 10.1017/S0033291719002137. [Epub ahead of print] No abstract available.

PMID:
31423953
2.

Predicting death by suicide using administrative health care system data: Can feedforward neural network models improve upon logistic regression models?

Sanderson M, Bulloch AGM, Wang J, Williamson T, Patten SB.

J Affect Disord. 2019 Jul 30;257:741-747. doi: 10.1016/j.jad.2019.07.063. [Epub ahead of print]

PMID:
31394413
3.

The Pharmacoepidemiology of Psychotropic Medication Use in Canadian Children from 2012 to 2016.

Pringsheim T, Stewart DG, Chan P, Tehrani A, Patten SB.

J Child Adolesc Psychopharmacol. 2019 Jul 29. doi: 10.1089/cap.2019.0018. [Epub ahead of print]

PMID:
31355670
4.

Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016.

Naghavi M; Global Burden of Disease Self-Harm Collaborators.

BMJ. 2019 Feb 6;364:l94. doi: 10.1136/bmj.l94.

5.

Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis.

Wu Y, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Conwell Y, de Man-van Ginkel JM, Fann JR, Fischer FH, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Harrison PA, Härter M, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki MD, Jetté N, Khamseh ME, Kiely KM, Kwan Y, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, McGuire A, Mohd-Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Reuter K, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford MD, Sung S, Tan PLL, Turner A, van Weert HC, White J, Whooley MA, Winkley K, Yamada M, Benedetti A, Thombs BD.

Psychol Med. 2019 Jul 12:1-13. doi: 10.1017/S0033291719001314. [Epub ahead of print]

PMID:
31298180
6.

The validity and reliability of screening measures for depression and anxiety disorders in rheumatoid arthritis.

Hitchon CA, Zhang L, Peschken CA, Lix LM, Graff LA, Fisk JD, Patten SB, Bolton J, Sareen J, El-Gabalawy R, Marriott J, Bernstein CN, Marrie R.

Arthritis Care Res (Hoboken). 2019 Jun 14. doi: 10.1002/acr.24011. [Epub ahead of print]

PMID:
31199570
7.

Seasonal variation in symptoms of depression: A Canadian population based study.

Lukmanji A, Williams JVA, Bulloch AGM, Bhattarai A, Patten SB.

J Affect Disord. 2019 Aug 1;255:142-149. doi: 10.1016/j.jad.2019.05.040. Epub 2019 May 23.

PMID:
31150944
8.

Gender differences in information needs and preferences regarding depression among individuals with multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis.

Marrie RA, Walker JR, Graff LA, Patten SB, Bolton JM, Marriott JJ, Fisk JD, Hitchon C, Peschken C, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Patient Educ Couns. 2019 Sep;102(9):1722-1729. doi: 10.1016/j.pec.2019.04.007. Epub 2019 Apr 6.

9.

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.

Levis B, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) Collaboration.

BMJ. 2019 Apr 9;365:l1476. doi: 10.1136/bmj.l1476. Erratum in: BMJ. 2019 Apr 12;365:l1781.

10.

Global assessment of migraine severity measure: preliminary evidence of construct validity.

Sajobi TT, Amoozegar F, Wang M, Wiebe N, Fiest KM, Patten SB, Jette N.

BMC Neurol. 2019 Apr 4;19(1):53. doi: 10.1186/s12883-019-1284-8.

11.

Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation? Reply from authors.

Frolkis AD, Vallerand IA, Patten SB, Kaplan GG.

Gut. 2019 Mar 20. pii: gutjnl-2019-318650. doi: 10.1136/gutjnl-2019-318650. [Epub ahead of print] No abstract available.

PMID:
30894399
12.

The Prevalence and Risk Factors of Undiagnosed Depression and Anxiety Disorders Among Patients With Inflammatory Bowel Disease.

Lewis K, Marrie RA, Bernstein CN, Graff LA, Patten SB, Sareen J, Fisk JD, Bolton JM; CIHR Team in Defining the Burden and Managing the Effects of Immune-Mediated Inflammatory Disease .

Inflamm Bowel Dis. 2019 Mar 19. pii: izz045. doi: 10.1093/ibd/izz045. [Epub ahead of print]

PMID:
30888037
13.

Assessment of the burden of diseases and injuries attributable to risk factors in Canada from 1990 to 2016: an analysis of the Global Burden of Disease Study.

Alam S, Lang JJ, Drucker AM, Gotay C, Kozloff N, Mate K, Patten SB, Orpana HM, Afshin A, Cahill LE.

CMAJ Open. 2019 Feb 28;7(1):E140-E148. doi: 10.9778/cmajo.20180137. Print 2019 Jan-Mar.

14.

Living with Migraine in Canada - A National Community-Based Study.

Altura KC, Patten SB, Williams JVA, Fiest KM, Jetté N.

Can J Neurol Sci. 2019 Mar;46(2):216-223. doi: 10.1017/cjn.2019.3. Epub 2019 Feb 28.

PMID:
30816083
15.

Depression and the risk of rheumatoid arthritis.

Vallerand IA, Patten SB, Barnabe C.

Curr Opin Rheumatol. 2019 May;31(3):279-284. doi: 10.1097/BOR.0000000000000597.

16.

Does neighborhood socioeconomic status predict the risk of preterm birth? A community-based Canadian cohort study.

Adhikari K, Patten SB, Williamson T, Patel AB, Premji S, Tough S, Letourneau N, Giesbrecht G, Metcalfe A.

BMJ Open. 2019 Feb 20;9(2):e025341. doi: 10.1136/bmjopen-2018-025341.

17.

Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription.

Josephson CB, Engbers JDT, Jette N, Patten SB, Singh S, Sajobi TT, Marshall D, Agha-Khani Y, Federico P, Mackie A, Macrodimitris S, McLane B, Pillay N, Sharma R, Wiebe S.

JAMA Neurol. 2019 Apr 1;76(4):440-446. doi: 10.1001/jamaneurol.2018.4561. Erratum in: JAMA Neurol. 2019 Mar 18;:.

PMID:
30688969
18.

Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata.

Vallerand IA, Lewinson RT, Parsons LM, Hardin J, Haber RM, Lowerison MW, Barnabe C, Patten SB.

JAMA Dermatol. 2019 Apr 1;155(4):475-479. doi: 10.1001/jamadermatol.2018.4398.

PMID:
30649133
19.

Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.

Whitehouse CE, Fisk JD, Bernstein CN, Berrigan LI, Bolton JM, Graff LA, Hitchon CA, Marriott JJ, Peschken CA, Sareen J, Walker JR, Stewart SH, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Neurology. 2019 Jan 11. pii: 10.1212/WNL.0000000000006854. doi: 10.1212/WNL.0000000000006854. [Epub ahead of print]

PMID:
30635487
20.

The "Clinician's illusion" and the epidemiology, diagnosis and treatment of depressive disorders.

Patten SB.

BMC Psychiatry. 2018 Dec 20;18(1):395. doi: 10.1186/s12888-018-1969-3.

21.

Vitiligo and major depressive disorder: A bidirectional population-based cohort study.

Vallerand IA, Lewinson RT, Parsons LM, Hardin J, Haber RM, Lowerison MW, Barnabe C, Patten SB.

J Am Acad Dermatol. 2019 May;80(5):1371-1379. doi: 10.1016/j.jaad.2018.11.047. Epub 2018 Dec 5.

PMID:
30528503
22.

Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-analysis.

Benedetti A, Wu Y, Levis B, Wilchesky M, Boruff J, Ioannidis JPA, Patten SB, Cuijpers P, Shrier I, Gilbody S, Ismail Z, McMillan D, Mitchell N, Ziegelstein RC, Thombs BD.

BMJ Open. 2018 Dec 4;8(12):e026598. doi: 10.1136/bmjopen-2018-026598.

23.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Mortality Collaborators.

Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

24.

Global Burden of Disease Study trends for Canada from 1990 to 2016.

Lang JJ, Alam S, Cahill LE, Drucker AM, Gotay C, Kayibanda JF, Kozloff N, Mate KKV, Patten SB, Orpana HM.

CMAJ. 2018 Nov 5;190(44):E1296-E1304. doi: 10.1503/cmaj.180698.

25.

Patient satisfaction with epilepsy surgery: what is important to patients?

Lunney M, Wahby S, Sauro KM, Atkinson MJ, Josephson CB, Girgis F, Singh S, Patten SB, Jetté N, Sajobi TT, Hader W, Wiebe S.

Epileptic Disord. 2018 Oct 1;20(5):364-373. doi: 10.1684/epd.2018.0995.

PMID:
30361186
26.

Increasing rates of arthroplasty for psoriatic arthritis in the United Kingdom between 1995 and 2010.

Lewinson RT, Vallerand IA, LaMothe JM, Parsons LM, Frolkis AD, Lowerison MW, Patten SB, Barnabe C.

Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23793. [Epub ahead of print]

PMID:
30354036
27.

Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression.

Frolkis AD, Vallerand IA, Shaheen AA, Lowerison MW, Swain MG, Barnabe C, Patten SB, Kaplan GG.

Gut. 2019 Sep;68(9):1606-1612. doi: 10.1136/gutjnl-2018-317182. Epub 2018 Oct 18.

PMID:
30337374
28.

Adherence to and Persistence with Antidepressant Medication during Pregnancy: Does It Differ by the Class of Antidepressant Medication Prescribed?

Adhikari K, Patten SB, Lee S, Metcalfe A.

Can J Psychiatry. 2019 Mar;64(3):199-208. doi: 10.1177/0706743718802809. Epub 2018 Sep 25.

PMID:
30252505
29.

Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review.

Gasim M, Bernstein CN, Graff LA, Patten SB, El-Gabalawy R, Sareen J, Bolton JM, Marriott JJ, Fisk JD, Marrie RA; CIHR team “Defining the burden and managing the effects of psychiatric comorbidity in chronic inflammatory disease”.

Mult Scler Relat Disord. 2018 Nov;26:124-156. doi: 10.1016/j.msard.2018.09.008. Epub 2018 Sep 12.

30.

Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4.

Ishihara M, Harel D, Levis B, Levis AW, Riehm KE, Saadat N, Azar M, Rice DB, Sanchez TA, Chiovitti MJ, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Arroll B, Bombardier CH, Butterworth P, Carter G, Clover K, Conwell Y, Goodyear-Smith F, Greeno CG, Hambridge J, Harrison PA, Hudson M, Jetté N, Kiely KM, McGuire A, Pence BW, Rooney AG, Sidebottom A, Simning A, Turner A, White J, Whooley MA, Winkley K, Benedetti A, Thombs BD.

Depress Anxiety. 2019 Jan;36(1):82-92. doi: 10.1002/da.22841. Epub 2018 Sep 20.

PMID:
30238571
31.

Major depressive episodes and mortality in the Canadian household population.

Patten SB, Williams JV, Bulloch AG.

J Affect Disord. 2019 Jan 1;242:165-171. doi: 10.1016/j.jad.2018.08.030. Epub 2018 Aug 14.

PMID:
30179790
32.

Factors associated with perceived need for mental health care in multiple sclerosis.

Orr J, Bernstein CN, Graff LA, Patten SB, Bolton JM, Sareen J, Marriott JJ, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Mult Scler Relat Disord. 2018 Oct;25:179-185. doi: 10.1016/j.msard.2018.07.043. Epub 2018 Jul 29.

33.

The effect of child hunger on educational attainment and early childbearing outcomes in a longitudinal population sample of Canadian youth.

McIntyre L, Kwok C, Patten SB.

Paediatr Child Health. 2018 Aug;23(5):e77-e84. doi: 10.1093/pch/pxx177. Epub 2017 Dec 22.

34.

Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study.

Vallerand IA, Lewinson RT, Frolkis AD, Lowerison MW, Kaplan GG, Swain MG, Bulloch AGM, Patten SB, Barnabe C.

RMD Open. 2018 Jul 11;4(2):e000670. doi: 10.1136/rmdopen-2018-000670. eCollection 2018.

35.

Safety of psychotropic medicines: looking beyond randomised evidence.

Barbui C, Patten SB.

Epidemiol Psychiatr Sci. 2018 Dec;27(6):529-530. doi: 10.1017/S2045796018000306. Epub 2018 Jul 13. No abstract available.

PMID:
30001764
36.

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study.

Hirsch L, Patten SB, Bresee L, Jette N, Pringsheim T.

BJPsych Open. 2018 Jul;4(4):256-261. doi: 10.1192/bjo.2018.33.

37.

Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.

Bernstein CN, Hitchon CA, Walld R, Bolton JM, Sareen J, Walker JR, Graff LA, Patten SB, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Inflamm Bowel Dis. 2019 Jan 10;25(2):360-368. doi: 10.1093/ibd/izy235.

PMID:
29986021
38.

Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases.

Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Jul - Aug;53:65-72. doi: 10.1016/j.genhosppsych.2018.06.001. Epub 2018 Jun 7.

39.

Social support and maternal mental health at 4 months and 1 year postpartum: analysis from the All Our Families cohort.

Hetherington E, McDonald S, Williamson T, Patten SB, Tough SC.

J Epidemiol Community Health. 2018 Oct;72(10):933-939. doi: 10.1136/jech-2017-210274. Epub 2018 Jun 19.

PMID:
29921649
40.

Psoriasis and the risk of foot and ankle tendinopathy or enthesopathy in the absence of psoriatic arthritis: a population-based study.

Lewinson RT, Vallerand IA, Parsons LM, LaMothe JM, Frolkis AD, Lowerison MW, Kaplan GG, Patten SB, Barnabe C.

RMD Open. 2018 May 21;4(1):e000668. doi: 10.1136/rmdopen-2018-000668. eCollection 2018.

41.

Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study.

McKay KA, Marrie RA, Fisk JD, Patten SB, Tremlett H.

Neuroepidemiology. 2018;51(1-2):1-10. doi: 10.1159/000488799. Epub 2018 May 15.

PMID:
29763935
42.

Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice.

Josephson CB, Engbers JDT, Jette N, Patten SB, Sajobi TT, Marshall D, Lowerison M, Wiebe S.

Epilepsy Behav. 2018 Jul;84:49-55. doi: 10.1016/j.yebeh.2018.04.012. Epub 2018 May 9.

PMID:
29753294
43.

Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews.

Levis B, Benedetti A, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Chiovitti MJ, Sanchez TA, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Steele RJ, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Beraldi A, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Chowdhary N, Clover K, Conwell Y, de Man-van Ginkel JM, Delgadillo J, Fann JR, Fischer FH, Fischler B, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Hambridge J, Harrison PA, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki M, Ismail K, Jetté N, Khamseh ME, Kiely KM, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, Marsh L, McGuire A, Mohd Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford L, Sung S, Tan PLL, Turner A, van der Feltz-Cornelis CM, van Weert HC, Vöhringer PA, White J, Whooley MA, Winkley K, Yamada M, Zhang Y, Thombs BD.

Br J Psychiatry. 2018 Jun;212(6):377-385. doi: 10.1192/bjp.2018.54. Epub 2018 May 2.

44.

Effects of depression and anxiety on quality of life in five common neurological disorders.

Prisnie JC, Sajobi TT, Wang M, Patten SB, Fiest KM, Bulloch AGM, Pringsheim T, Wiebe S, Jette N.

Gen Hosp Psychiatry. 2018 May - Jun;52:58-63. doi: 10.1016/j.genhosppsych.2018.03.009. Epub 2018 Apr 4.

PMID:
29684713
45.

Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple Sclerosis.

Marrie RA, Patten SB, Berrigan LI, Tremlett H, Wolfson C, Warren S, Leung S, Fiest KM, McKay KA, Fisk JD; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Int J MS Care. 2018 Mar-Apr;20(2):76-84. doi: 10.7224/1537-2073.2016-110.

46.

The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Bernstein CN, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott J, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Inflamm Bowel Dis. 2018 Apr 13. doi: 10.1093/ibd/izy068. [Epub ahead of print]

47.

Depressive Symptomatology, Syndromal Depression, and HIV-Associated Neurocognitive Disorder (HAND).

Goodkin K, Patten SB.

Can J Psychiatry. 2018 May;63(5):284-286. doi: 10.1177/0706743718754537. No abstract available.

48.

Is depression screening in patients with acne critical?: reply from authors.

Vallerand IA, Lewinson RT, Parsons LM, Lowerison MW, Frolkis AD, Kaplan GG, Barnabe C, Bulloch AGM, Patten SB.

Br J Dermatol. 2018 Jul;179(1):227-228. doi: 10.1111/bjd.16673. Epub 2018 May 27. No abstract available.

PMID:
29654704
49.

Validating screening tools for depression in Parkinson's disease.

Kadhim S, Pringsheim T, Le A, Fiest KM, Patten SB, Prisnie JC, Gill S, Bulloch AGM, Hu B, Jette N.

Mov Disord. 2018 Jul;33(7):1184-1186. doi: 10.1002/mds.27371. Epub 2018 Mar 24. No abstract available.

PMID:
29573354
50.

Psychiatric comorbidity is associated with disability progression in multiple sclerosis.

McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, Campbell T, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurology. 2018 Apr 10;90(15):e1316-e1323. doi: 10.1212/WNL.0000000000005302. Epub 2018 Mar 9.

Supplemental Content

Loading ...
Support Center